Not independent
Tenure on this board
17.4 yrs
Also a director at
Ares Management Corp (ARES)
Meeting calendar
ARCC · Special meeting · Friday, August 8, 2025
Ares Capital Corp
10 nominees · 1 ballot item.
One proposal being voted at the Special Meeting: Proposal 1 to authorize the Company to sell or issue shares of its common stock below its NAV under specified conditions; the Board recommends voting FOR.
Market cap
$13.3B
1Y TSR
-6.4%
Board grade
B-
Record date
May 13, 2025
Filing
DEF 14A
Meeting concluded · Aug 8, 2025
Follow how the vote landed and what changed on Ares Capital Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot1
- 1
AUTHORIZATION OF THE COMPANY TO SELL OR OTHERWISE ISSUE SHARES OF ITS COMMON STOCK AT A PRICE BELOW ITS THEN CURRENT NET ASSET VALUE PER SHARE SUBJECT TO THE CONDITIONS SET FORTH IN THIS PROPOSAL
ManagementBoard: FORThe Company seeks stockholder approval to issue common stock below NAV in offerings up to 25% of outstanding shares, during a twelve-month period, to provide flexibility to pursue attractive investment opportunities and to maintain access to capital while managing debt covenants; the Board has approved and recommends stockholders vote in favor.
Director elections
Nominees on the ballot10
Not independent
Tenure on this board
10.7 yrs
Also a director at
Ares Management Corp (ARES)
Not independent
Tenure on this board
1.0 yrs
Not independent
Tenure on this board
3.7 yrs
Independent
Tenure on this board
16.2 yrs
Independent
Tenure on this board
4.3 yrs
Independent
Tenure on this board
10.1 yrs
Also a director at
American Shared Hospital Services (AMS)
Independent
Tenure on this board
13.8 yrs
Independent
Tenure on this board
6.6 yrs
Independent
Tenure on this board
22.5 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | MORGAN STANLEY | 2.1% | 15,023,928 | $271M |
| 2 | UBS Group AG | 1.5% | 11,096,173 | $200M |
| 3 | VAN ECK ASSOCIATES CORP | 1.5% | 10,887,111 | $196M |
| 4 | STRS OHIO | 1.5% | 10,500,000 | $189M |
| 5 | JPMORGAN CHASE CO | 1.1% | 7,673,289 | $136M |
| 6 | Generali Asset Management SPA SGR | 1.1% | 7,547,995 | $136M |
| 7 | TWO SIGMA INVESTMENTS, LP | 1.0% | 7,306,344 | $132M |
| 8 | BANK OF AMERICA CORP /DE/ | 1.0% | 6,859,550 | $124M |
| 9 | Legal General Group Plc | 0.8% | 5,975,008 | $108M |
| 10 | LPL Financial LLC | 0.6% | 4,038,185 | $73M |
Peers
Nearest market capOther Financial Services sector meetings6
Upcoming shareholder meetings at Ares Capital Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Corebridge Financial IncCRBG
Special meeting·Jul 30, 2026·$13.1B
Equitable Holdings IncEQH
Special meeting·Jul 30, 2026·$12.4B
Blackstone Secured Lending FundBXSL
Annual meeting·Sep 24, 2026·$5.5B
Corvel CorpCRVL
Annual meeting·Aug 6, 2026·$3.2B
Hilltop Holdings IncHTH
Annual meeting·Jul 23, 2026·$2.3B
Capital Southwest CorpCSWC
Annual meeting·Jul 22, 2026·$1.5B
Reference
Frequently asked questions
- When is the Ares Capital Corp 2025 special meeting?
- Ares Capital Corp (ARCC) holds its 2025 special shareholder meeting on Friday, August 8, 2025.
- What is the record date for the Ares Capital Corp 2025 meeting?
- The record date for the Ares Capital Corp 2025 meeting is Tuesday, May 13, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Ares Capital Corp's 2025 meeting?
- The board is presenting 10 director nominees at the Ares Capital Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Ares Capital Corp 2025 meeting?
- Shareholders will vote on 1 proposal at the Ares Capital Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.